Pandemic preparedness strategies must go beyond vaccines

Sci Transl Med. 2023 Apr 5;15(690):eadd3055. doi: 10.1126/scitranslmed.add3055. Epub 2023 Apr 5.

Authors

Rajesh Gupta^{1

2

3

4}, Lisa A Purcell^{1

2

3

4}, Davide Corti^{1

2

3

4}, Herbert W Virgin^{1

2

3

4}

Affiliations

¹ Rajesh Gupta is at Vir Biotechnology, San Francisco, CA, USA. Email: rgupta@vir.bio.
² Lisa A. Purcell is at Vir Biotechnology, San Francisco, CA, USA.
³ Davide Corti is at Humabs Biomed SA (a Vir Biotechnology subsidiary), Bellinzona, Switzerland.
⁴ Herbert W. Virgin is at Altos Labs, Redwood City, CA, and is an adjunct professor at Washington University School of Medicine, St. Louis, MO, USA, and the University of Texas Southwestern Medical Center, Dallas, TX, USA.

PMID: 37018420
DOI: 10.1126/scitranslmed.add3055

Abstract

Monoclonal antibodies can fill a critical gap to help stop the next infectious disease outbreak from becoming the next pandemic.

Publication types

Editorial

MeSH terms

Disease Outbreaks / prevention & control
Humans
Influenza, Human* / epidemiology
Pandemics / prevention & control
Vaccines*

Substances

Vaccines